Patents by Inventor Tamra L. Barker

Tamra L. Barker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for achieving sustained therapeutic drug concentrations in a subject
    Patent number: 10525051
    Abstract: Provided herein are compounds and methods for achieving a sustained therapeutic effect of small molecule anti-cancer agents when administered in vivo.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: January 7, 2020
    Assignee: Nektar Therapeutics
    Inventors: Michael A. Eldon, Shibani S. Harite, Tamra L. Barker
  • COMPOSITIONS AND METHODS FOR ACHIEVING SUSTAINED THERAPEUTIC DRUG CONCENTRATIONS IN A SUBJECT
    Publication number: 20180028525
    Abstract: Provided herein are compounds and methods for achieving a sustained therapeutic effect of small molecule anti-cancer agents when administered in vivo.
    Type: Application
    Filed: October 3, 2017
    Publication date: February 1, 2018
    Inventors: Michael A. Eldon, Shibani S. Harite, Tamra L. Barker
  • Methods for treating humans having brain cancer
    Patent number: 9801873
    Abstract: Among other things, a method of treating a human having brain cancer is, the method comprising administering via a non-continuous dosing regimen to the human having brain cancer, a therapeutically effective amount of a pharmaceutical composition comprising a prodrug or a pharmaceutically acceptable salt thereof, wherein the non-continuous dosing regimen comprises administering the pharmaceutical composition no more frequently than once every seven days for at least two dosings.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: October 31, 2017
    Assignee: Nektar Therapeutics
    Inventors: Michael A. Eldon, Shibani S. Harite, Tamra L. Barker
  • Methods for Treating Humans Having Brain Cancer
    Publication number: 20150087668
    Abstract: Among other things, a method of treating a human having brain cancer is, the method comprising administering via a non-continuous dosing regimen to the human having brain cancer, a therapeutically effective amount of a pharmaceutical composition comprising a prodrug or a pharmaceutically acceptable salt thereof, wherein the non-continuous dosing regimen comprises administering the pharmaceutical composition no more frequently than once every seven days for at least two dosings.
    Type: Application
    Filed: November 26, 2014
    Publication date: March 26, 2015
    Applicant: Nektar Therapeutics
    Inventors: Michael A. Eldon, Shibani S. Harite, Tamra L. Barker
  • Compositions and methods for achieving sustained therapeutic drug concentrations in a subject
    Patent number: 8906353
    Abstract: Provided herein are compounds and methods for achieving a sustained therapeutic effect of small molecule anti-cancer agents when administered in vivo.
    Type: Grant
    Filed: September 23, 2009
    Date of Patent: December 9, 2014
    Assignee: Nektar Therapeutics
    Inventors: Michael A. Eldon, Shibani S. Harite, Tamra L. Barker
  • Compositions and Methods for Achieving Sustained Therapeutic Drug Concentrations in a Subject
    Publication number: 20110269789
    Abstract: Provided herein are compounds and methods for achieving a sustained therapeutic effect of small molecule anti-cancer agents when administered in vivo.
    Type: Application
    Filed: September 23, 2009
    Publication date: November 3, 2011
    Applicant: Nektar Therapeutics
    Inventors: Michael A. Eldon, Shibani S. Harite, Tamra L. Barker